Detailed Information on Publication Record
2005
A significance of additional chromosomal aberrations and other variables on post transplantation outcome of patients with CML
VRANOVA, V., Stanislav KATINA, G. KIRSCHNEROVA, M. MISTRIK, J. LAKOTA et. al.Basic information
Original name
A significance of additional chromosomal aberrations and other variables on post transplantation outcome of patients with CML
Authors
VRANOVA, V. (703 Slovakia, guarantor), Stanislav KATINA (703 Slovakia, belonging to the institution), G. KIRSCHNEROVA (703 Slovakia), M. MISTRIK (703 Slovakia), J. LAKOTA (703 Slovakia), J. HORAKOVA, (703 Slovakia) and A. TOTHOVA (703 Slovakia)
Edition
Neoplasma, Blarislava, Slovakia, Slovak Academy of Sciences, 2005, 0028-2685
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10103 Statistics and probability
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.731
RIV identification code
RIV/00216224:14310/05:00061111
Organization unit
Faculty of Science
UT WoS
000232222100005
Keywords in English
chronic myeloic leukemia CML; allogenic stem cell transplantation SCT; additional chromosomal aberations; post transplantation outcome; survival analysis
Tags
International impact, Reviewed
Změněno: 21/2/2013 15:55, doc. PaedDr. RNDr. Stanislav Katina, Ph.D.
Abstract
V originále
Chronic myeloic leukemia (CML) is a malignant disease of hematopoietic stem cell characterized by the bcr/abl gene rearrangement. Allogeneic transplantation of stem cells (SCT) is a routinely used treatment method of patients with this diagnosis and remains the only curative mode of treatment. From January 1990 to December 2002, 78 patients with CML underwent allogeneic transplantation and were examined at the Department of Genetics in the National Cancer Institute in Bratislava. Using conventional cytogenetic and FISH 6 patients (7.7%) showed additional chromosomal changes before SCT. These patients had statistically worse post transplantation prognosis compared to the patients without additional changes before SCT (mean survival in month+/-standard error (58.08 (+/-6.70) vs. 5.17 (+/-0.98), p-value=0.001), patient mortality (67% vs. 31%)). In addition five other variables were evaluated for transplant outcome, namely, patient's age at the time of transplantation, sibling or non-sibling donor, higher than 1st chronic phase CML, time from diagnosis to transplantation and sex of donor and recipient. Only the comparison of HLA-identical sibling transplantation to unrelated donor transplantation was statistically significant (mean survival in month- 56.6 (+/-7.2) vs. 13 (+/-0.0), patient mortality 31% vs. 67%).
Links
CZ.1.07/2.2.00/15.0203, interní kód MU |
|